| Literature DB >> 16393663 |
Bin Wan1, James T Fleming, Terry W Schultz, Gary S Sayler.
Abstract
Depleted uranium (DU) is a by-product of the uranium enrichment process and shares chemical properties with natural and enriched uranium. To investigate the toxic effects of environmental DU exposure on the immune system, we examined the influences of DU (in the form of uranyl nitrate) on viability and immune function as well as cytokine gene expression in murine peritoneal macrophages and splenic CD4+ T cells. Macrophages and CD4+ T cells were exposed to various concentrations of DU, and cell death via apoptosis and necrosis was analyzed using annexin-V/propidium iodide assay. DU cytotoxicity in both cell types was concentration dependent, with macrophage apoptosis and necrosis occurring within 24 hr at 100 microM DU exposure, whereas CD4+ T cells underwent cell death at 500 microM DU exposure. Noncytotoxic concentrations for macrophages and CD4+ T cells were determined as 50 and 100 microM, respectively. Lymphoproliferation analysis indicated that macrophage accessory cell function was altered with 200 microM DU after exposure times as short as 2 hr. Microarray and real-time reverse-transcriptase polymerase chain reaction analyses revealed that DU alters gene expression patterns in both cell types. The most differentially expressed genes were related to signal transduction, such as c-jun, NF- kappa Bp65, neurotrophic factors (e.g., Mdk), chemokine and chemokine receptors (e.g., TECK/CCL25), and interleukins such as IL-10 and IL-5, indicating a possible involvement of DU in cancer development, autoimmune diseases, and T helper 2 polarization of T cells. The results are a first step in identifying molecular targets for the toxicity of DU and the elucidation of the molecular mechanisms for the immune modulation ability of DU.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16393663 PMCID: PMC1332661 DOI: 10.1289/ehp.8085
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Primer sequences used in quantitative RT-PCR for differentially expressed genes
| Target | Sequences | Amplicon size (bp) |
|---|---|---|
| F: 5′ -CAT GGG TCT TGG GAA GAG AA-3′ | ||
| R: 5′-CAT TCC CAG AGG AAT TGC AT-3′ | 194 | |
| F: 5′-ACC GAG GCT TCT TCC TTC TC-3′ | ||
| R: 5′-GGC TCC AAA TTC CTT CTT CC-3′ | 230 | |
| F: 5′-TTC ATG GAG CTT CGA GTC CT-3′ | ||
| R: 5′-AGC ATG TTG ATT GGG GAC AT-3′ | 299 | |
| F: 5-TGA GAA CTT GAC TGG TTG CG-3′ | ||
| R: 5′-AAA GTC CAT CGT TCT GGT CG-3′ | 222 | |
| F: 5′-TGG TGA AAT TGC AAG AGC TG-3′ | ||
| R: 5′-TGT GTG CGT ACC CAA GAT GT-3′ | 119 | |
| F: 5′-ACA CAA TCG GTT GCA AAA CA-3′ | ||
| R: 5′-GGA AAG TCA GCT TCG TCA GG-3′ | 128 | |
| F: 5′-GTC CCT ACT CAT AAA AAT CAC CA-3′ | ||
| R: 5′-GAA TAG CAT TTC CAC AGT ACC C-3′ | 105 | |
| F: 5′-TGA TGA CAT CAA GAA GGT GGT GAA G-3′ | ||
| R: 5′-TCC T TG GAG GCC ATG TAG GCC AT-3′ | 240 |
Abbreviations: F, forward primer; R, reverse primer.
Sequences are from Lee et al. (2000).
Figure 1Cell apoptosis and necrosis under DU exposure. (A) Macrophages were treated with 0 (control), 20, 50, 100, or 200 μM DU for 24 hr. (B) CD4+ T cells were treated with 0 (negative control), 1, 10, 100, or 500 μM DU, 1 mM NaNO3, or 1 μg/mL staurosporine (positive control) for 24 hr. Data are presented as percentage of cells in the apoptotic or necrotic state and are the means of triplicate experiments. Error bars represent SD.
*Difference from negative control is statistically significant (p < 0.05).
Figure 2Representative bright-field and atomic force photomicrographs of macrophages with or without DU exposure. The cells were cultured in medium without or with 100 μM DU (as uranyl nitrate) for 24 hr and then processed for microscopy. Bright-field images (40 × magnification) of control (A) and DU-treated cells (B); the rough membrane structure of DU-treated cells was shown in B. Atomic force microscopy images of single control (C) and DU-treated cells (D), with or without nucleus area, respectively. The apoptotic body is presented in D as smaller separated bodies. The arrows in B and D indicate cells undergoing apoptosis after 24 hr of 100 μM DU exposure. Arrow in C indicates the nucleus feature of a normal cell.
Figure 3Effect of DU on the accessory cell function of peritoneal adherent macrophages. The effect of DU on lymphocyte (CD4+ T cell) proliferation was determined by MTT assay, which indirectly reflects the accessory cell function of macrophages in promoting lymphocyte proliferation. Results are expressed in optical density values read at 562 nm wavelength as mean and SD of triplicate analyses.
*Difference from control is statistically significant (p < 0.05).
Differentially regulated genes in DU-exposed peritoneal adherent macrophages as determined by array analysis.
| Gene abbreviation | Gene symbol | Accession no. | Gene description | Gene group | Ratio | 95% CI | |
|---|---|---|---|---|---|---|---|
| Up-regulated gene expression | |||||||
| | NM_009045 | avian reticuloendotheliosis viral (v-rel) oncogene homolog A | Signal transduction | 5.8 × 10–8 | 3.9 | 6.3–2.4 | |
| | AF004874 | latent TGF-beta binding protein-2 | Binding protein | 1.8 × 10–6 | 3.2 | 5.3–2.0 | |
| | NM_011720 | wingless related MMTV integration site 8b | Developmental factors | 9.3 × 10–6 | 3.2 | 5.4–1.9 | |
| | NM_010784 | midkine | Neurotrophic group | 1.5 × 10–5 | 3.1 | 5.2–1.9 | |
| | NM_010591 | Jun oncogene | Signal transduction | 7.1 × 10–5 | 3.2 | 5.8–1.8 | |
| | NM_016896 | Nfkb inducing kinase | Apoptosis related | 1.5 × 10–3 | 2.4 | 4.0–1.4 | |
| | NM_007540 | brain derived neurotrophic factor | Neurotrophic group | 2.4 × 10–3 | 1.7 | 2.5–1.2 | |
| | NM_009896 | cytokine inducible SH2-containing protein 1 | Signal transduction | 2.8 × 10–3 | 2.4 | 4.2–1.4 | |
| | NM_010849 | myelocytomatosis oncogene | Signal transduction | 7.2 × 10–3 | 2.2 | 3.8–1.2 | |
| | NM_010942 | neuron specific gene family member 1 | Signal transduction | 7.8 × 10–3 | 2.0 | 3.3–1.2 | |
| | NM_010548 | interleukin 10 | Interleukin | 8.2 × 10–3 | 1.7 | 2.5–1.2 | |
| | NM_009283 | signal transducer and activator of transcription 1 | Signal transduction | 9.2 × 10–3 | 2.0 | 3.4–1.2 | |
| | NM_008353 | interleukin 12 receptor, beta 1 | Interleukin receptor | 1.1 × 10–2 | 1.6 | 2.4–1.1 | |
| | NM_007707 | cytokine inducible SH2-containing protein 3 | Signal transduction | 1.1 × 10–2 | 1.8 | 2.8–1.1 | |
| | AF188286 | bone morphogenetic protein 9 | TGF-beta family | 1.4 × 10–2 | 1.8 | 2.7–1.1 | |
| | NM_008543 | MAD homolog 7 (Drosophila) | Signal transduction | 1.9 × 10–2 | 1.6 | 2.5–1.1 | |
| | AF185284 | toll-like receptor 2 | Cell surface protein | 1.9 × 10–2 | 1.8 | 2.8–1.1 | |
| | NM_007795 | cardiotrophin 1 | Cytokine and receptors | 1.9 × 10–2 | 1.9 | 3.4–1.1 | |
| | M68513 | mouse eph-related receptor tyrosine kinase (Mek4) | Eph family | 2.1 × 10–2 | 1.6 | 2.3–1.1 | |
| | NM_008607 | matrix metalloproteinase 13 | Protease or related factor | 2.2 × 10–2 | 1.9 | 3.3–1.1 | |
| | AF092734 | growth/differentiation factor 11 | TGF-beta family | 3.2 × 10–2 | 1.8 | 3.1–1.0 | |
| | D49921 | glial cell line-derived neurotrophic factor (GDNF) | Neurotrophic group | 3.5 × 10–2 | 1.6 | 2.4–1.0 | |
| | M95632 | integrin beta-7 subunit | Intergrin | 2.9 × 10–2 | 1.7 | 2.9–1.0 | |
| | NM_008611 | matrix metalloproteinase 8 | Protease or related factor | 4.9 × 10–2 | 1.6 | 2.5–1.0 | |
| Down-regulated gene expression | |||||||
| | NM_011604 | toll-like receptor 6 | Cell surface protein | 2.7 × 10–2 | 0.6 | 0.9–0.4 | |
| | NM_011198 | prostaglandin-endoperoxide synthase 2 | Apoptosis related | 2.3 × 10–2 | 0.6 | 0.9–0.4 | |
| | NM_011693 | vascular cell adhesion molecule 1 | Adhesion molecule | 1.2 × 10–2 | 0.5 | 0.9–0.3 | |
| | NM_009805 | caspase homolog | Apoptosis related | 1.1 × 10–2 | 0.6 | 0.9–0.4 | |
| | NM_009144 | stromal cell derived factor 5 | Apoptosis related | 7.3 × 10–4 | 0.6 | 0.8–0.4 | |
Results are from three individual experiments.
From Sigma-Genosys (http://www.sigmaaldrich.com/catalog/search/ProductDetail/GENOSYS/G2041).
From GenBank (http://www.ncbi.nlm.nih.gov/Genbank/).
p-Values in the two-tailed Z-tests for the comparison between control and DU treatments.
The ratio expression values for the average expression values of each gene between DU and control, that is, ratio = intensity value from DU-treated cells divided by that from control cells.
Confidence intervals (CIs) determined for ratios, p < 0.05.
Differentially regulated genes in DU-exposed CD4+ T cells as determined by array analysis.
| Gene abbreviation | Gene symbol | Accession no. | Gene description | Gene group | Ratio | 95% CI | |
|---|---|---|---|---|---|---|---|
| Up-regulated gene expression | |||||||
| | NM_009138 | small inducible cytokine A25 | Chemokine | 1.5 × 10–14 | 4.2 | 6.2–2.9 | |
| | NM_010784 | midkine | Neurotrophic group | 2.9 × 10–7 | 3.0 | 4.7–1.9 | |
| | NM_010558 | interleukin 5 | Interleukin | 9.5 × 10–4 | 1.9 | 2.9–1.3 | |
| | NM_009505 | vascular endothelial growth factor | Angiogenic factor | 2.5 × 10–5 | 1.8 | 2.2–1.4 | |
| Down-regulated gene expression | |||||||
| | M68513 | eph-related receptor tyrosine kinase (Mek4) | Eph family | 4.0 × 10–8 | 0.5 | 0.6–0.4 | |
| | NM_009916 | chemokine (C-C) receptor 4 | Chemokine receptor | 1.8 × 10–5 | 0.6 | 0.8–0.5 | |
| | NM_008501 | leukemia inhibitory factor | Cytokine and receptors | 3.0 × 10–5 | 0.6 | 0.8–0.4 | |
| | U08339 | BALB/c putative growth factor GDF7 (Gdf7) gene | TGF-beta superfamily | 2.4 × 10–4 | 0.5 | 0.7–0.3 | |
| | NM_007897 | early B-cell factor | Signal transduction | 3.7 × 10–4 | 0.5 | 0.7–0.4 | |
| | L24495 | CD27 antigen | TNF superfamily | 6.4 × 10–4 | 0.6 | 0.8–0.4 | |
| | AF088902 | SLIT1 protein | Developmental factor | 9.2 × 10–4 | 0.7 | 0.8–0.5 | |
| | NM_009142 | small inducible cytokine subfamily D, 1 | Chemokine | 1.2 × 10–3 | 0.4 | 0.7–0.2 | |
| | NM_008539 | MAD homolog 1 ( | Signal transduction | 1.3 × 10–3 | 0.6 | 0.8–0.5 | |
| | L16462 | hemopoietic-specific early response protein | Apoptosis related | 1.5 × 10–3 | 0.6 | 0.8–0.4 | |
Results are from three individual experiments.
From Sigma-Genosys (http://www.sigmaaldrich.com/catalog/search/ProductDetail/GENOSYS/G2041).
From GenBank (http://www.ncbi.nlm.nih.gov/Genbank/).
p-Values in the two-tailed Z-tests for the comparison between control and DU treatments.
The ratio expression values for the average expression values of each gene between DU and control, that is, ratio = intensity value from DU-treated cells divided by that from control cells.
95% Confidence intervals (CIs) determined for ratios, p < 0.05.
Comparison of the gene expression ratios in macrophages determined by microarray and quantitative RT-PCR analysis.
| Gene abbreviation | Array ratios | RT-PCR ratio |
|---|---|---|
| 3.1 | 3.2 | |
| 3.2 | 1.9 | |
| 1.8 | 1.6 | |
| 2.0 | 2.2 | |
| 1.7 | 6.9 | |
| 0.6 | 0.6 | |
| 3.0 | 1.9 | |
| 1.9 | 3.2 |
The gene was differentially expressed in macrophages.
The gene was differentially expressed in CD4+ T cells.
Results from triplicate s (n = 3).